Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Spot On Sciences Launches Searchable Database of Dried Blood Spot Methods

Published: Friday, September 07, 2012
Last Updated: Friday, September 07, 2012
Bookmark and Share
Spot On Science’s free, publicly accessible database aids researchers by providing rapid access to published dried blood spot (DBS) test methods.

Spot On Sciences, Inc., an Austin-based medical device company, has just released a web-based searchable database that focuses exclusively on advances made in dried blood spot (DBS) methods and technology over the last 40 years. The database, the first and only one currently accessible to the public, is designed to help advance DBS adoption and assist bioscience researchers with work being done in diagnostic testing and medical research. Recent advances in DBS technology have elevated its value both as a sampling tool and vital component of laboratory analysis.

"Those of us in interested in DBS have been waiting for this type of research tool for a long time” said Dr. John Repass, former research scientist at M.D. Anderson Cancer Center and current Chief Scientist at ARQ Genetics. “This database allows an easier way for me to search and navigate through the myriad of studies scattered over hundreds of sources. It’s a great time-saver for anyone doing research and developing DBS methods.”

Spot On Sciences, Inc.’s CEO, Dr. Jeanette Hill, explained that “there’s been an explosion of methods and papers devoted to DBS and we detected the need within the bioscience community for this type of site-based resource. Anyone can come to our site and can browse by analyte or keywords to track down key information from over 1,000 entries.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!